Drug LitigationSecond Half of Pregnancy Most Dangerous for Pregnant Celexa Patients

January 4, 2012

According to prominent health care experts, Celexa (citalopram) has been associated with fetal persistent pulmonary hypertension (PPHN) as well as birth defects affecting a newborn’s heart, brain and skull, and abdominal organs. Moreover, ingestion of Celexa (citalopram) during the second half of a woman’s pregnancy markedly increases the probability that the developing child will be born with these birth defects.

 

Is this news to you? Unfortunately, the fact that the risk level of Celexa (citalopram) and other selective serotonin reuptake inhibitors (SSRIs) changes over the life of a pregnancy is news to a lot of pregnant patients. And in many cases, these patients are left with very real feelings of regret, wishing that they had known more about this dangerous drug and done more to protect the child growing in their womb.

 

The parents who gave birth to injured children can’t change the past, but they can fight for their children’s future. The lawyers at Nachawati Law Group fight for victims of dangerous drugs like Celexa (citalopram). Truth be told, it’s thanks to our experienced, expert attorneys and specialists that many, many victims of injury have been compensated for their suffering. We may be able to help you, too. Talk to us today for your free consultation. Just call 1.866.545.8364 or email [email protected] . We’re ready to fight for you!


———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.